Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
1999-10-05
2003-12-23
Gitomer, Ralph (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C536S004100
Reexamination Certificate
active
06667161
ABSTRACT:
FIELD OF THE INVENTION
The current invention relates to the design, synthesis, and biochemical evaluation of chromogenic substrate compounds for sialidases of bacterial, viral, protozoa, and vertebrate (including human) origin. In particular, this invention provides a novel class of effective compounds as chromogenic substrates of these sialidases which yield chromogenic products after reactions catalyzed by sialidase take place. Also provided are methods of making these substrate compounds, methods of diagnosis and prognosis of sialidase related diseases using these substrate compounds.
BACKGROUND OF THE INVENTION
Sialidase (EC 3.2.1.18, also known as neuraminidase, acylneuraminyl hydrolase) is a protein enzyme produced by many organisms such as bacteria, viruses, protozoa, and vertebrates including humans (Hirst, 1941). This class of enzymes catalyzes the hydrolysis of a terminal sialic acids which are &agr;-ketosidically linked to glycoproteins, glycolipids, and polysaccharides through an O-glycosidic bond (Drzeniek, 1972).
There are a large number of biological functions ascribed to sialidase enzyme, including cell-cell recognition phenomena and the pathogenicity of some infections by sialidase-bearing microorganisms (Schauer, 1985). In bacteria, sialidase helps bacterial adhesion to tissues, and provides additional nutritional sources (Crennell, et al., 1994). In the case of the influenza virus, sialidase is one of two surface glycoproteins and is considered to be important for both transporting the virus through mucin (Kienk and Rott, 1988) and for the elution of virus progeny from infected cells (Palese, et al., 1974). In a parasite,
Trypanosoma cruzi
, a sialidase (also known as trans-sialidase) removes sialic acids from infected cells and decorates its own surface with these sialic acids. In humans, silaidases are involved in protein digestion, immune responses, and cell proliferation. Abnormal production of sialidases may lead to serious human diseases such as sialidosis or increased
Pseudomonas aeruginosa
infection in cystic fibrosis patients.
Since sialidases are associated with many diseases, a color-producing substrate of sialidase would be an excellent diagnostic or prognostic reagent for sialidase-related diseases. For instance, sialidase level is elevated in bacterial vaginosis (Briselden, et al., 1992). Measurement of sialidase level in the vaginal samples could be used to diagnose bacterial vaginosis. In periodontal disease caused by bacterial infection, it has been shown that the presence of sialidase increases the colonization of harmful bacteria (Liljemark, et al., 1989). In influenza virus, viral sialidases are elevated in the mouth of patients. Measurement of sialidase level in the throat swab samples could be used to diagnose influenza virus. The cell invasion form of
T. cruzi
, Trypomastigote, expresses high levels of trans-sialidase activity; therefore, measurement of trans-sialidase level could be used for diagnosis of
T. cruzi
infection and for monitoring disease progress (Cross and Tackle, 1993). In cystic fibrosis patients,
Pseudomonas aeruginosa
infection is one of the leading causes of death. Sialidase was shown to be involved in the disease progress (Cacalano, et al., 1992). Sialidase is also related to the regulation of cell proliferation (Bratosin, et al., 1995), the clearance of plasma proteins (Bonten, et al., 1996), and the catabolism of gangliosides and glycoproteins (Gornati, et al., 1997).
The structure of sialidase has been extensively studied using numerous antigenic variants from several crystallographic studies (Colman, 1989, Varghese, et al., 1983; Colman, et al., 1983; Varghese, et al. 1992; Taylor and Itzstein, 1994). A key feature arising from these studies has been the fact that despite up to 50% variation in the primary sequence of the enzyme, the active site residues are highly conserved in both influenza A and B virus strains.
N-Acetylneuraminic acid, the product resulting from sialidase-mediated hydrolysis of polysaccharides, glycoproteins, and glycolipids, is shown below with the numbering system used to denote the carbon atoms:
4-position modified N-acetylneuraminic acid analogs (Neu5Ac) have previously been described (Turner, et al., 1997):
2-O-(4-methylumbelliferyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-cyanoumbelliferyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(2-nitrophenyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-nitrophenyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-resorufin)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-4-chloro-3-indolyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-3-indolyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-indolyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-[4-(4nitrophenylazo)phenyl]-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-([4-(4-nitrophenylazo)resocinyl]-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-methoxyphenyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-dimethylaminophenyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-chloro-1-naphthyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(6-bromo-2-naphthyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-methylumbelliferyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(2-nitrophenyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-nitrophenyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-cyanoumbelliferyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-resorufin)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-4-chloro-3-indolyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-3-indolyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-indolyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-[4-(4nitrophenylazo)phenyl]-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-[4-(4-nitrophenylazo)resocinyl]-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-methoxyphenyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-dimethylaminophenyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(6-bromo-2-naphthyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-chloro-1-naphthyl)-4-deoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-methylumbelliferyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(2-nitrophenyl)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-methylumbelliferyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(2-nitrophenyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-nitrophenyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-cyanoumbelliferyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-resorufin)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-4-chloro-3-indolyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-3-indolyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-indolyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-[4-(4-nitrophenylazo)phenyl]-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-[4-(4-nitropheynazo)resorcinyl]-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-methoxyphenyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-dimethylaminophenyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-chloro-1-naphthyl)-4-ethoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-methylumbelliferyl)-4-fluoro-N-acetylneuraminic acid-alpha-ketoside,
2-O-(2-nitrophenyl)-4-fluoro-N-acetylneuraminic acid-alpha-ketoside,
2-O-(4-nitrophenyl)-4-fluoro-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-cyanoumbelliferyl)-4-fluoro-N-acetylneuraminic acid-alpha-ketoside,
2-O-(3-resorufin)-4-methoxy-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-4-chloro-3 indolyl)-4-fluoro-N-acetylneuraminic acid-alpha-ketoside,
2-O-(5-bromo-3-indolyl)-4-fluoro-N-acetylneuraminic acid-alpha-ketoside,
2-O-[4-(4-nitrophenylazo)phenyl]-4-fluoro-N-acetylneuraminic acid-alpha-
Johnson Stephen C.
Lou Ming
Yan Shijia
Gitomer Ralph
Ibbex, Inc.
Saliwanchik Lloyd & Saliwanchik
LandOfFree
Chromogenic substrates of sialidase of bacterial, viral,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chromogenic substrates of sialidase of bacterial, viral,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromogenic substrates of sialidase of bacterial, viral,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3114450